社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
东阳光长江药业(01558)
15.880
+0.000
0.00%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
公司概况
公司名称
东阳光长江药业
所属市场
SEHK
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.hec-changjiang.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
宜昌东阳光长江药业股份有限公司是一家主要从事抗感染、内分泌及代谢类疾病等治疗领域产品开发、生产及销售的中国公司。该公司的主要产品包括可威（磷酸奥司他韦胶囊及颗粒）、尔同舒（苯溴马隆片）、欧美宁（替米沙坦片）、琳罗星（盐酸莫西沙星片），以及奥美沙坦酯片等产品。该公司还从事集采业务。该公司主要在国内市场开展业务。
2025-08-07
收购
联合公告以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出有条件私有化的最新进展(1) 达成实施条件及实施合并(2) 就零碎股安排委聘代理人
联合公告以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出有条件私有化的最新进展(1) 达成实施条件及实施合并(2) 就零碎股安排委聘代理人
2025-08-05
收购
联合公告撤销H股上市地位及撤销上市地位的预期时间表及实行换股
联合公告撤销H股上市地位及撤销上市地位的预期时间表及实行换股
2025-07-31
股息分派
特别股息(更新)
特别股息(更新)
2025-07-31
收购
有关特别股息之联合公告
有关特别股息之联合公告
2025-07-23
收购
联合公告异议股东行使权利的结果
联合公告异议股东行使权利的结果
2025-07-21
收购
联合公告(1) 于二零二五年七月二十一日（星期一）举行的有关以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出附条件的私有化之建议的临时股东大会及H股类别股东大会的投票表决结果(2) 建议撤销上市地位及最后交易日(3) 建议特别股息及(4) 有关异议股东行使权利的资料
联合公告(1) 于二零二五年七月二十一日（星期一）举行的有关以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出附条件的私有化之建议的临时股东大会及H股类别股东大会的投票表决结果(2) 建议撤销上市地位及最后交易日(3) 建议特别股息及(4) 有关异议股东行使权利的资料
2025-06-30
股息分派
特别股息(更新)
特别股息(更新)
2025-06-29
收购
综合文件(1) 以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出附条件的私有化之建议(2) 建议特别股息(3) 建议撤销上市地位(4) 临时股东大会通告及(5) H股类别股东大会通告
综合文件(1) 以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出附条件的私有化之建议(2) 建议特别股息(3) 建议撤销上市地位(4) 临时股东大会通告及(5) H股类别股东大会通告
2025-06-29
收购
联合公告(1)以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出有条件私有化之建议(2)建议撤销上市地位及(3)寄发综合文件
联合公告(1)以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出有条件私有化之建议(2)建议撤销上市地位及(3)寄发综合文件
2025-06-27
收购
联合公告以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出附条件的私有化之建议 达成全部前提条件
联合公告以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出附条件的私有化之建议 达成全部前提条件
2025-06-18
收购
联合公告以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出附前提条件的私有化之建议部分达成一项前提条件及延长截止日期
联合公告以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出附前提条件的私有化之建议部分达成一项前提条件及延长截止日期
2025-06-09
收购
联合公告有关以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出附前提条件的私有化之建议的月度更新及一项前提条件的达成
联合公告有关以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出附前提条件的私有化之建议的月度更新及一项前提条件的达成
2025-05-09
收购
联合公告有关以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出附前提条件的私有化之建议的月度更新
联合公告有关以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出附前提条件的私有化之建议的月度更新
2025-04-28
年度报告
年度报告 2024
年度报告 2024
2025-04-10
收购
联合公告有关以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出附前提条件的私有化之建议的月度更新
联合公告有关以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出附前提条件的私有化之建议的月度更新
加载更多
分时
5日
日
周
月
数据加载中...
最高
15.880
今开
15.880
量比
0.00
最低
15.880
昨收
15.880
换手率
0.00%
热议股票
{"pagemeta":{"title":"东阳光长江药业(01558)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东阳光长江药业(01558)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东阳光长江药业,01558,东阳光长江药业股票,东阳光长江药业股票老虎,东阳光长江药业股票老虎国际,东阳光长江药业行情,东阳光长江药业股票行情,东阳光长江药业股价,东阳光长江药业股市,东阳光长江药业股票价格,东阳光长江药业股票交易,东阳光长江药业股票购买,东阳光长江药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东阳光长江药业(01558)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东阳光长江药业(01558)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"fillings","symbol":"01558","data":{"stockData":{"symbol":"01558","market":"HK","secType":"STK","nameCN":"东阳光长江药业","latestPrice":15.88,"timestamp":1783670400000,"preClose":15.88,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":653767700,"shares":879967700,"eps":0.6342389825262812,"marketStatus":"停牌","change":0,"latestTime":"07-10 16:00:00","open":15.88,"high":15.88,"low":15.88,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.6342389825262812,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783906200000},"marketStatusCode":7,"adr":0,"listingDate":1451318400000,"exchange":"SEHK","adjPreClose":15.88,"dividendRate":0.094458,"openAndCloseTimeList":[[1783647000000,1783656000000],[1783659600000,1783670400000]],"volumeRatio":0,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"tweetData":null,"newsData":null,"noticeData":{"listData":[{"cdn_pdf":true,"hasAttachments":false,"id":"19956666","market":"hk","labels":[],"media":"港交所","original_id":"N.HKGm8uwkrFX3","pdf_url":"https://static.tigerbbs.com/72b140bba54b445698c04717a84e17ce","pub_time":1754518080000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"联合公告以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出有条件私有化的最新进展(1) 达成实施条件及实施合并(2) 就零碎股安排委聘代理人","symbol":"01558","title":"联合公告以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出有条件私有化的最新进展(1) 达成实施条件及实施合并(2) 就零碎股安排委聘代理人","titleType":"收购","type":"hkAnnouncement","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0807/2025080700012_c.pdf","us_notice_code":"公告及通告 - [《收购守则》所指的要约公司刊发的公告 / 《收购守则》所指的受要约公司刊发的公告 / 私有化/撤销或取消...更多]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易披露","type_name_en":"Announcement","titleTypeEn":"Acquisition","event_type":"important_notice","event_name":"收购","pubTime":"2025-08-07 06:08","pubTimestamp":1754518080,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19946135","market":"hk","labels":[],"media":"港交所","original_id":"N.HKAEAQSFUyHb","pdf_url":"https://static.tigerbbs.com/b370a359e3154a48855b2a75863def09","pub_time":1754345040000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"联合公告撤销H股上市地位及撤销上市地位的预期时间表及实行换股","symbol":"01558","title":"联合公告撤销H股上市地位及撤销上市地位的预期时间表及实行换股","titleType":"收购","type":"hkAnnouncement","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0805/2025080500008_c.pdf","us_notice_code":"公告及通告 - [《收购守则》所指的要约公司刊发的公告 / 《收购守则》所指的受要约公司刊发的公告 / 私有化/撤销或取消...更多]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易披露","type_name_en":"Announcement","titleTypeEn":"Acquisition","event_type":"important_notice","event_name":"收购","pubTime":"2025-08-05 06:04","pubTimestamp":1754345040,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19930390","market":"hk","labels":[],"media":"港交所","original_id":"N.HKD81Yqjm1No","pdf_url":"https://static.tigerbbs.com/eb884e16915d434badad285b7dc64f05","pub_time":1753956720000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"特别股息(更新)","symbol":"01558","title":"特别股息(更新)","titleType":"股息分派","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0731/2025073101410_c.pdf","us_notice_code":"公告及通告 - [股息或分派（公告表格）]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Dividend","event_type":"important_notice","event_name":"股息分派","pubTime":"2025-07-31 18:12","pubTimestamp":1753956720,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19930372","market":"hk","labels":[],"media":"港交所","original_id":"N.HKChg3ELdf49","pdf_url":"https://static.tigerbbs.com/d72f8a50414d446585ea5da471dbd764","pub_time":1753956600000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"有关特别股息之联合公告","symbol":"01558","title":"有关特别股息之联合公告","titleType":"收购","type":"hkAnnouncement","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0731/2025073101404_c.pdf","us_notice_code":"公告及通告 - [《收购守则》所指的要约公司刊发的公告 / 《收购守则》所指的受要约公司刊发的公告 / 股息或分派 / 暂...更多]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易披露","type_name_en":"Announcement","titleTypeEn":"Acquisition","event_type":"important_notice","event_name":"收购","pubTime":"2025-07-31 18:10","pubTimestamp":1753956600,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19903695","market":"hk","labels":[],"media":"港交所","original_id":"N.HK9PZPtnknws","pdf_url":"https://static.tigerbbs.com/beaa9febf13040d29f596c04fc828dcf","pub_time":1753267560000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"联合公告异议股东行使权利的结果","symbol":"01558","title":"联合公告异议股东行使权利的结果","titleType":"收购","type":"hkAnnouncement","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0723/2025072300917_c.pdf","us_notice_code":"公告及通告 - [《收购守则》所指的要约公司刊发的公告 / 《收购守则》所指的受要约公司刊发的公告 / 私有化/撤销或取消...更多]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易披露","type_name_en":"Announcement","titleTypeEn":"Acquisition","event_type":"important_notice","event_name":"收购","pubTime":"2025-07-23 18:46","pubTimestamp":1753267560,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19895929","market":"hk","labels":[],"media":"港交所","original_id":"N.HKFtGHDX1io6","pdf_url":"https://static.tigerbbs.com/c991c71a268041a8b5e37ef7d97266ba","pub_time":1753092180000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"联合公告(1) 于二零二五年七月二十一日（星期一）举行的有关以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出附条件的私有化之建议的临时股东大会及H股类别股东大会的投票表决结果(2) 建议撤销上市地位及最后交易日(3) 建议特别股息及(4) 有关异议股东行使权利的资料","symbol":"01558","title":"联合公告(1) 于二零二五年七月二十一日（星期一）举行的有关以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出附条件的私有化之建议的临时股东大会及H股类别股东大会的投票表决结果(2) 建议撤销上市地位及最后交易日(3) 建议特别股息及(4) 有关异议股东行使权利的资料","titleType":"收购","type":"hkAnnouncement","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0721/2025072100845_c.pdf","us_notice_code":"公告及通告 - [《收购守则》所指的要约公司刊发的公告 / 《收购守则》所指的受要约公司刊发的公告 / 股东特别大会的结果...更多]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易披露","type_name_en":"Announcement","titleTypeEn":"Acquisition","event_type":"important_notice","event_name":"收购","pubTime":"2025-07-21 18:03","pubTimestamp":1753092180,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19824324","market":"hk","labels":[],"media":"港交所","original_id":"N.HK4WnTpy11Tj","pdf_url":"https://static.tigerbbs.com/1c6b8776702046f3893eae751f831716","pub_time":1751278500000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"特别股息(更新)","symbol":"01558","title":"特别股息(更新)","titleType":"股息分派","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0630/2025063002320_c.pdf","us_notice_code":"公告及通告 - [股息或分派（公告表格）]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Dividend","event_type":"important_notice","event_name":"股息分派","pubTime":"2025-06-30 18:15","pubTimestamp":1751278500,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19821734","market":"hk","labels":[],"media":"港交所","original_id":"N.HKHyRCmdY6Uk","pdf_url":"https://static.tigerbbs.com/e3a2431c8f7243c0b73388a5aa3219d7","pub_time":1751192100000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"综合文件(1) 以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出附条件的私有化之建议(2) 建议特别股息(3) 建议撤销上市地位(4) 临时股东大会通告及(5) H股类别股东大会通告","symbol":"01558","title":"综合文件(1) 以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出附条件的私有化之建议(2) 建议特别股息(3) 建议撤销上市地位(4) 临时股东大会通告及(5) H股类别股东大会通告","titleType":"收购","type":"hkAnnouncement","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0629/2025062900022_c.pdf","us_notice_code":"通函 - [《收购守则》所指的受要约公司发出的文件 / 《收购守则》所指的要约公司发出的文件 / 私有化/撤销证券上市]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易披露","type_name_en":"Announcement","titleTypeEn":"Acquisition","event_type":"important_notice","event_name":"收购","pubTime":"2025-06-29 18:15","pubTimestamp":1751192100,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19821723","market":"hk","labels":[],"media":"港交所","original_id":"N.HK8zGX9jb2Jq","pdf_url":"https://static.tigerbbs.com/be038083287947dc8dd08045e8de6e8b","pub_time":1751191860000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"联合公告(1)以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出有条件私有化之建议(2)建议撤销上市地位及(3)寄发综合文件","symbol":"01558","title":"联合公告(1)以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出有条件私有化之建议(2)建议撤销上市地位及(3)寄发综合文件","titleType":"收购","type":"hkAnnouncement","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0629/2025062900016_c.pdf","us_notice_code":"公告及通告 - [《收购守则》所指的受要约公司刊发的公告 / 《收购守则》所指的要约公司刊发的公告 / 私有化/撤销或取消...更多]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易披露","type_name_en":"Announcement","titleTypeEn":"Acquisition","event_type":"important_notice","event_name":"收购","pubTime":"2025-06-29 18:11","pubTimestamp":1751191860,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19816221","market":"hk","labels":[],"media":"港交所","original_id":"N.HK4K5PJGC3c7","pdf_url":"https://static.tigerbbs.com/4703c336ce7948aea8af3419953b24e9","pub_time":1751018580000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"联合公告以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出附条件的私有化之建议 达成全部前提条件","symbol":"01558","title":"联合公告以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出附条件的私有化之建议 达成全部前提条件","titleType":"收购","type":"hkAnnouncement","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0627/2025062701643_c.pdf","us_notice_code":"公告及通告 - [《收购守则》所指的要约公司刊发的公告 / 《收购守则》所指的受要约公司刊发的公告 / 集团重组或协议安排...更多]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易披露","type_name_en":"Announcement","titleTypeEn":"Acquisition","event_type":"important_notice","event_name":"收购","pubTime":"2025-06-27 18:03","pubTimestamp":1751018580,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19784221","market":"hk","labels":[],"media":"港交所","original_id":"N.HKHzLYoT5Yfe","pdf_url":"https://static.tigerbbs.com/5eab1574ab394282911ff28d11828d74","pub_time":1750241400000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"联合公告以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出附前提条件的私有化之建议部分达成一项前提条件及延长截止日期","symbol":"01558","title":"联合公告以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出附前提条件的私有化之建议部分达成一项前提条件及延长截止日期","titleType":"收购","type":"hkAnnouncement","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0618/2025061800833_c.pdf","us_notice_code":"公告及通告 - [《收购守则》所指的要约公司刊发的公告 / 《收购守则》所指的受要约公司刊发的公告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易披露","type_name_en":"Announcement","titleTypeEn":"Acquisition","event_type":"important_notice","event_name":"收购","pubTime":"2025-06-18 18:10","pubTimestamp":1750241400,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19751264","market":"hk","labels":[],"media":"港交所","original_id":"N.HK9DRd56KaLs","pdf_url":"https://static.tigerbbs.com/9924899452e64ef1a8b23658ae028f79","pub_time":1749470640000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"联合公告有关以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出附前提条件的私有化之建议的月度更新及一项前提条件的达成","symbol":"01558","title":"联合公告有关以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出附前提条件的私有化之建议的月度更新及一项前提条件的达成","titleType":"收购","type":"hkAnnouncement","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0609/2025060900999_c.pdf","us_notice_code":"公告及通告 - [《收购守则》所指的要约公司刊发的公告 / 《收购守则》所指的受要约公司刊发的公告 / 内幕消息]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易披露","type_name_en":"Announcement","titleTypeEn":"Acquisition","event_type":"important_notice","event_name":"收购","pubTime":"2025-06-09 20:04","pubTimestamp":1749470640,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19622940","market":"hk","labels":[],"media":"港交所","original_id":"N.HK5SCpsDpKCt","pdf_url":"https://static.tigerbbs.com/fef8c34a55604072ba35557c6e7151f2","pub_time":1746795600000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"联合公告有关以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出附前提条件的私有化之建议的月度更新","symbol":"01558","title":"联合公告有关以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出附前提条件的私有化之建议的月度更新","titleType":"收购","type":"hkAnnouncement","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0509/2025050901158_c.pdf","us_notice_code":"公告及通告 - [《收购守则》所指的要约公司刊发的公告 / 《收购守则》所指的受要约公司刊发的公告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易披露","type_name_en":"Announcement","titleTypeEn":"Acquisition","event_type":"important_notice","event_name":"收购","pubTime":"2025-05-09 21:00","pubTimestamp":1746795600,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19525436","market":"hk","labels":[],"media":"港交所","original_id":"N.HK7Z6zNXGqUq","pdf_url":"https://static.tigerbbs.com/142fb58fb0344d7f82ef6c5211d1c9ea","pub_time":1745796840000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"年度报告 2024","symbol":"01558","title":"年度报告 2024","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0428/2025042800166_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [年报]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2025-04-28 07:34","pubTimestamp":1745796840,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19374592","market":"hk","labels":[],"media":"港交所","original_id":"N.HK3GMhggasVf","pdf_url":"https://static.tigerbbs.com/84c0b89e08294c658dc63b391b63f7a7","pub_time":1744292400000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"联合公告有关以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出附前提条件的私有化之建议的月度更新","symbol":"01558","title":"联合公告有关以吸收合并宜昌东阳光长江药业股份有限公司之方式由广东东阳光药业股份有限公司对宜昌东阳光长江药业股份有限公司作出附前提条件的私有化之建议的月度更新","titleType":"收购","type":"hkAnnouncement","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0410/2025041001374_c.pdf","us_notice_code":"公告及通告 - [《收购守则》所指的要约公司刊发的公告 / 《收购守则》所指的受要约公司刊发的公告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易披露","type_name_en":"Announcement","titleTypeEn":"Acquisition","event_type":"important_notice","event_name":"收购","pubTime":"2025-04-10 21:40","pubTimestamp":1744292400,"notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.hec-changjiang.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0.1769},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0353},{"period":"1month","weight":-0.0095},{"period":"3month","weight":-0.0664},{"period":"6month","weight":-0.0784},{"period":"1year","weight":0.0061},{"period":"ytd","weight":-0.0568}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"宜昌东阳光长江药业股份有限公司是一家主要从事抗感染、内分泌及代谢类疾病等治疗领域产品开发、生产及销售的中国公司。该公司的主要产品包括可威（磷酸奥司他韦胶囊及颗粒）、尔同舒（苯溴马隆片）、欧美宁（替米沙坦片）、琳罗星（盐酸莫西沙星片），以及奥美沙坦酯片等产品。该公司还从事集采业务。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.043062},{"month":2,"riseRate":0.8,"avgChangeRate":0.085594},{"month":3,"riseRate":0.4,"avgChangeRate":-0.060017},{"month":4,"riseRate":0.7,"avgChangeRate":0.045285},{"month":5,"riseRate":0.5,"avgChangeRate":-0.005165},{"month":6,"riseRate":0.7,"avgChangeRate":0.069778},{"month":7,"riseRate":0.5,"avgChangeRate":-0.04333},{"month":8,"riseRate":0.3,"avgChangeRate":-0.027578},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.045757},{"month":10,"riseRate":0.444444,"avgChangeRate":0.024639},{"month":11,"riseRate":0.777778,"avgChangeRate":0.132189},{"month":12,"riseRate":0.555556,"avgChangeRate":0.011021}],"exchange":"SEHK","name":"东阳光长江药业","nameEN":"HEC CJ PHARM"},"aProfile":null}}}